Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

233

HTML

2298

Figures (1-5)

242

Tables (1-5)

221

Sum=2994

Oct 14, 2005 (publication date) through Dec 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Oct 14, 2005; 11(38): 5938-5943
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.5938

Table 3 The percentages of cell cycle phases and PI

^aP<0.05,

^bP<0.01, vs group D;

^dP<0.01, vs group C;

^fP<0.01, vs group B.

Citation: Tan B, Huang JF, Wei Q, Zhang H, Ni RZ. Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats. World J Gastroenterol 2005; 11(38): 5938-5943
URL: https://www.wjgnet.com/1007-9327/full/v11/i38/5938.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i38.5938